tiprankstipranks
Advertisement
Advertisement

NKTX Stock Latest News

Nkarta price target lowered to $9 from $25 at Evercore ISI
The FlyNkarta price target lowered to $9 from $25 at Evercore ISI
13d ago
NKTX
Nkarta Buy Rating Reaffirmed as NKX019 Autoimmune Trials Advance; $16 Price Target Maintained
PremiumRatings
Nkarta Buy Rating Reaffirmed as NKX019 Autoimmune Trials Advance; $16 Price Target Maintained
18d ago
NKTX
Nkarta reports Q1 EPS (37c), consensus (37c)
PremiumThe Fly
Nkarta reports Q1 EPS (37c), consensus (37c)
18d ago
NKTX
Nkarta (NKTX): Constructive Buy Rating on Leadership, Strategic Positioning, and Upcoming Value-Creating Milestones
PremiumRatings
Nkarta (NKTX): Constructive Buy Rating on Leadership, Strategic Positioning, and Upcoming Value-Creating Milestones
1M ago
NKTX
Nkarta announces agreement with FDA on changes to Ntrust-1, Ntrust-2 trials
PremiumThe Fly
Nkarta announces agreement with FDA on changes to Ntrust-1, Ntrust-2 trials
2M ago
NKTX
Nkarta price target lowered to $12 from $14 at Mizuho
PremiumThe FlyNkarta price target lowered to $12 from $14 at Mizuho
2M ago
NKTX
Buy Rating Initiated on NKX019’s Differentiated CAR‑NK Platform and De‑Risked Autoimmune Opportunity Ahead of 2026 Proof‑of‑Concept Data
Premium
Ratings
Buy Rating Initiated on NKX019’s Differentiated CAR‑NK Platform and De‑Risked Autoimmune Opportunity Ahead of 2026 Proof‑of‑Concept Data
2M ago
NKTX
Nkarta price target raised to $11 from $10 at Needham
Premium
The Fly
Nkarta price target raised to $11 from $10 at Needham
2M ago
NKTX
Nkarta Launches $100 Million At-the-Market Stock Offering
PremiumCompany Announcements
Nkarta Launches $100 Million At-the-Market Stock Offering
2M ago
8K
NKTX
Nkarta files $350M mixed securities shelf
PremiumThe Fly
Nkarta files $350M mixed securities shelf
2M ago
NKTX
Nkarta reports Q4 EPS (37c), consensus (29c)
PremiumThe Fly
Nkarta reports Q4 EPS (37c), consensus (29c)
2M ago
NKTX
Is NKTX a Buy, Before Earnings?
PremiumPre-Earnings
Is NKTX a Buy, Before Earnings?
2M ago
NKTX
Nkarta price target lowered to $11 from $12 at Stifel
PremiumThe FlyNkarta price target lowered to $11 from $12 at Stifel
7M ago
NKTX
Nkarta’s Strategic Management and Financial Strength Justify Buy Rating and $10 Target Price
Premium
Ratings
Nkarta’s Strategic Management and Financial Strength Justify Buy Rating and $10 Target Price
7M ago
NKTX
Nkarta Advances NKX019 Program Amid Financial Stability
Premium
Company Announcements
Nkarta Advances NKX019 Program Amid Financial Stability
7M ago
NKTX
Nkarta reports Q3 EPS (29c), consensus (30c)
PremiumThe Fly
Nkarta reports Q3 EPS (29c), consensus (30c)
7M ago
NKTX
Nkarta’s NKX019 Study: A Promising Step in Autoimmune Disease Treatment
PremiumCompany Announcements
Nkarta’s NKX019 Study: A Promising Step in Autoimmune Disease Treatment
7M ago
NKTX
Nkarta, Inc. Advances CAR NK Cell Therapy Study for Immune-Mediated Diseases
PremiumCompany Announcements
Nkarta, Inc. Advances CAR NK Cell Therapy Study for Immune-Mediated Diseases
7M ago
NKTX
Nkarta price target lowered to $12 from $14 at Stifel
PremiumThe Fly
Nkarta price target lowered to $12 from $14 at Stifel
10M ago
NKTX
Promising Developments in Nkarta’s NKX019 Trials Justify Buy Rating
PremiumRatingsPromising Developments in Nkarta’s NKX019 Trials Justify Buy Rating
10M ago
NKTX
Nkarta’s Strong Financial Position and Promising Clinical Progress Support Buy Rating
Premium
Ratings
Nkarta’s Strong Financial Position and Promising Clinical Progress Support Buy Rating
10M ago
NKTX
Nkarta, Inc. Reports Q2 2025 Financial Results
Premium
Company Announcements
Nkarta, Inc. Reports Q2 2025 Financial Results
10M ago
NKTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >